A Novel Approach to Successful ABO-Incompatible High-Titer Renal Transplantation

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2285-2288

  Uchida, J ^a   Iwai, T ^a   Kato, M ^a   Machida, Y ^a   Naganuma, T ^a   Kumada, N ^a   Yoshimura, R ^a   Kawashima, H ^a   Kim, T ^a   Nakatani, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO SYSTEM; CASE REPORT; FEMALE; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SPLENECTOMY; TREATMENT OUTCOME;

EID: 51249119202     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.018     Document Type: Article

References (11)

1. Takahashi K., Saito K., Takahara S., et al., Japanese ABO-Incompatible Kidney Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 (2004) 1089
2. Stegall M.D., Dean P.G., and Gloor J.M. ABO-incompatible kidney transplantation. Transplantation 78 (2004) 635
3. Gloor J.M., Lager D.J., Fidler M.E., et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 80 (2005) 1572
4. Shimmura H., Tanabe K., Ishida H., et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation 80 (2005) 985
5. Sawada T., Fuchinoue S., Kawase T., et al. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation. Clin Transplant 18 (2004) 254
6. Segev D.L., Simpkins C.E., Warren D.S., et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 5 (2005) 2570
7. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 19 (2005) 76
8. Mannami M., and Mitsuhata N. Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil. Transplantation 79 (2005) 1756
9. Golay J., Zaffaroni L., Vaccari T., et al. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 95 (2000) 3900
10. Vieira C.A., Agarwal A., Book B.K., et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 77 (2004) 542
11. 2 without splenectomy appropriate for ABO-incompatible renal transplant?. Am J Transplant 5 (2005) 3019